Researchers have developed a GPS vaccine that guides the immune system to create broadly neutralizing antibodies against HIV. For many years, researchers have been trying to develop an HIV vaccine ...

A study has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes ...

An HIV vaccine candidate developed at the Duke Human Vaccine Institute (DHVI) triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a ...

LA JOLLA, CA and NEW YORK, NY—A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of ...

Discovery brings us one step closer to vaccine and treatment for prevalent virus. Image courtesy of the Centers for Disease Control. Scientists at The University of Texas at Austin, in collaboration ...

How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...

Since it was first identified in 1983, HIV has infected more than 85 million people and caused some 40 million deaths worldwide. While medication known as pre-exposure prophylaxis, or PrEP, can ...

Rice University bioengineer Omid Veiseh has been awarded a $2.2 million grant from the Gates Foundation to develop implantable cell factory platforms that can deliver therapeutic antibodies over ...

Typically, an antibody-drug, an anti-idiotype antibody (anti-ID Ab, see the schematic image) attaches itself to the idiotype of another antibody. An idiotype is the particular arrangement of idiotopes ...